Emerging therapy options for IgG4-related disease.
Journal article
Lanzillotta M. et al, (2021), Expert review of clinical immunology, 17, 471 - 483
The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.
Journal article
Cargill T. and Culver EL., (2021), Frontiers in immunology, 12
Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'.
Journal article
Peters RJR. et al, (2020), Annals of the rheumatic diseases
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Journal article
Culver EL. et al, (2020), Liver international : official journal of the International Association for the Study of the Liver, 40, 2744 - 2757
Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses.
Journal article
Unger P-PA. et al, (2020), European journal of immunology, 50, 1113 - 1125
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.
Journal article
Löhr J-M. et al, (2020), United European gastroenterology journal, 8, 637 - 666
Review of primary sclerosing cholangitis with increased IgG4 levels.
Journal article
Manganis CD. et al, (2020), World journal of gastroenterology, 26, 3126 - 3144
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.
Journal article
Goodchild G. et al, (2020), Clinical medicine (London, England), 20, e32 - e39
Expansion of a Novel Subset of PD1+CXCR5-CD4+ T Peripheral Helper Cells in IgG4-Related Disease.
Journal article
Cargill T. et al, (2020), Clinical and translational gastroenterology, 11
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Journal article
Wallace ZS. et al, (2020), Annals of the rheumatic diseases, 79, 77 - 87
IgG4-related disease
Journal article
Culver EL. et al, (2019), Medicine (United Kingdom), 47, 804 - 807
Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis
Journal article
Culver EL. et al, (2019), Journal of Gastroenterology and Hepatology, 34, 1878 - 1886
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
Journal article
Cargill T. et al, (2019), Clinical and translational gastroenterology, 10
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
Journal article
Camilleri M. et al, (2019), Clinical and translational gastroenterology, 10
Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
Journal article
Cargill T. et al, (2019), Clinical and translational gastroenterology
Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis
Journal article
Cargill T. et al, (2019), Clinical and Translational Gastroenterology, 10, e00020 - e00020
Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
Journal article
Selvaraj EA. et al, (2019), World Journal of Gastroenterology, 25, 644 - 658
Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort
Journal article
Evans RDR. et al, (2019), Kidney International Reports, 4, 48 - 58
An International Multispecialty Validation Study of the IgG4‐Related Disease Responder Index
Journal article
Wallace ZS. et al, (2018), Arthritis Care & Research, 70, 1671 - 1678
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
Journal article
Zenouzi R. et al, (2018), Alimentary Pharmacology & Therapeutics, 48, 169 - 178